- Home
- MAG vs IRON Comparison
MAG vs IRON Comparison
Compare MAG & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAG
- IRON
- Stock Information
- Founded
- MAG N/A
- IRON 2017
- Country
- MAG Canada
- IRON United States
- Employees
- MAG N/A
- IRON N/A
- Industry
- MAG Precious Metals
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- MAG Basic Materials
- IRON Health Care
- Exchange
- MAG Nasdaq
- IRON Nasdaq
- Market Cap
- MAG 2.2B
- IRON 2.0B
- IPO Year
- MAG N/A
- IRON N/A
- Fundamental
- Price
- MAG $24.47
- IRON $60.76
- Analyst Decision
- MAG Hold
- IRON Strong Buy
- Analyst Count
- MAG 3
- IRON 10
- Target Price
- MAG $22.67
- IRON $97.80
- AVG Volume (30 Days)
- MAG 1.9M
- IRON 299.1K
- Earning Date
- MAG 08-11-2025
- IRON 08-07-2025
- Dividend Yield
- MAG 2.22%
- IRON N/A
- EPS Growth
- MAG 67.82
- IRON N/A
- EPS
- MAG 0.99
- IRON N/A
- Revenue
- MAG N/A
- IRON N/A
- Revenue This Year
- MAG N/A
- IRON N/A
- Revenue Next Year
- MAG N/A
- IRON N/A
- P/E Ratio
- MAG $24.70
- IRON N/A
- Revenue Growth
- MAG N/A
- IRON N/A
- 52 Week Low
- MAG $11.72
- IRON $30.82
- 52 Week High
- MAG $25.09
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- MAG 68.09
- IRON 56.26
- Support Level
- MAG $23.43
- IRON $59.74
- Resistance Level
- MAG $25.09
- IRON $63.51
- Average True Range (ATR)
- MAG 0.53
- IRON 2.05
- MACD
- MAG 0.08
- IRON -0.00
- Stochastic Oscillator
- MAG 76.69
- IRON 44.17
About MAG MAG Silver Corporation
MAG Silver Corp is a Canadian mining company. It is focused on advancing high-grade, district-scale precious metals projects in the Americas. The Company's principal asset is in the Juanicipio Mine located in Zacatecas, Mexico, which produced around 4,000 tonnes per day commercially. The company is also Interested in the Larder project. Its operations are Juanicipio, Deer Trail, and Larder. The Juanicipio Mine recognizes silver, gold, lead, and zinc revenue from concentrate sales.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.